Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

169.46
BATS BZX Real-Time Price
As of 2:50pm ET
 -1.38 / -0.81%
Today’s Change
130.09
Today|||52-Week Range
176.64
+4.39%
Year-to-Date
Amgen's Shameful Silence Covers Up Reasons for FDA Drug Rejection
9:33am / TheStreet.com - Paid Partner Content
3 Cheap Dividend Stocks You Can Buy Right Now
Aug 19 / MotleyFool.com - Paid Partner Content
Amgen Gets CRL for Secondary Hyperparathyroidism Drug
9:07am / Zacks.com - Paid Partner Content
Gilead May Be Better Off Splitting Itself in Two, Analysts Say
Aug 18 / TheStreet.com - Paid Partner Content
J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use
Aug 24 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen
Aug 18 / Zacks.com - Paid Partner Content
Biotechs Rally on Pfizer/Medivation Deal
Aug 22 / TheStreet.com - Paid Partner Content
Cytokinetics' Amyotrophic Lateral Sclerosis Study Enrolled
Aug 18 / Zacks.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data
Aug 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close170.84
Today’s open169.97
Day’s range169.14 - 171.42
Volume134,387
Average volume (3 months)2,856,432
Market cap$127.8B
Dividend yield2.36%
Data as of 2:50pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+9.46%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+6.49%
P/E ratio17.4
Price/Sales5.83
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.83-1.03%
BIIBBiogen-6.67-2.16%
BAXBaxter International...+0.07+0.15%
ILMNIllumina Inc-0.70-0.41%
Data as of 2:51pm ET, 08/25/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$2.80
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers

Search for Jobs